Study Stopped
Lack of recruitment
Pain in Complex Regional Pain Syndrome
Modulation of Pain Sensitization in Complex Regional Pain Syndrome
1 other identifier
interventional
8
1 country
1
Brief Summary
CRPS is a complex pain condition that usually develops in response to trauma and immobilization which is very painful and debilitating. There is no consensus about the underlying mechanisms which might be a combination of mentally and physically factors. At the moment, better diagnostic clarification and better pain relieving treatment is needed. The aim of this study is to investigate changes in the perception of pain in patients with Complex Regional Pain Syndrome (CRPS), and whether this perception can be affected by treatment with transcutaneous electrical nerve stimulation (TENS) on the painful area. The study will consist of two parts. One in which patients' perception of pain will be compared to the perception of pain in healthy controls. Another in which the included patients are randomly allocated into a group receiving medical treatment plus treatment with transcutaneous electrical nerve stimulation on the painful area or in a group receiving medical treatment as usual (MED).Patients will be evaluated four times. At the start of the study, immediately after treatment, and again at 6 and 12 months after treatment. The evaluation consists of an overall assessment of pain, response to standardized sensory stimuli, and questionnaires about quality of life, physical capacity and mentally/socially well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 14, 2020
CompletedStudy Start
First participant enrolled
February 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedApril 24, 2023
April 1, 2023
1.5 years
November 30, 2020
April 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
NRS pain score
Change in the NRS pain score pre- and post TENS treatment compared with the MED group (controls)
Pre- and 1 week post TENS
Secondary Outcomes (10)
Mechanical pressure pain threshold
Pre, retest and 1, 12 weeks post TENS
Temporal summation
Pre, retest and 1, 12 weeks post TENS
Thermal sensitivity
Pre, retest and 1, 12 weeks post TENS
Conditioned pain modulation
Pre, retest and 1, 12 weeks post TENS
Use of Analgesics
Pre and 1, 12 weeks post TENS
- +5 more secondary outcomes
Study Arms (2)
Group MED
NO INTERVENTIONA group of participants that receives treatment as usual that consists of medicinal treatment, prescribed by a specialist doctor (Carsten Kock-Jensen, MD) from the CRPS clinic and will be monitored using patients' medicinal records.
Group TENS
EXPERIMENTALA group of participants that receives transcutaneous electrical nerve stimulation (TENS) which is an inexpensive, noninvasive and safe treatment for pain.
Interventions
Conventional TENS will be performed using two electrodes placed on the involved extremity and with the following stimulation parameters; a frequency of 100 Hz, pulse duration 50-100 ms, and at an intensity gradually increased until the patient feels a strong, tolerable and non-painful sensation (18, 19). The intensity is incrementally increased based on patient feedback. Patients will receive guidelines on how to use the TENS device at home and will over a period of 30 days self-administer TENS as needed. Patients is to fill out a predefined schedule on paper each day to monitor dose.
Eligibility Criteria
You may qualify if:
- CRPS according to existing diagnostic criteria
- Numeric Rating Scale (NRS) pain \>4
You may not qualify if:
- Prior use of TENS for the past 6 months
- Active inflammatory conditions
- Pacemaker
- Comorbid disease that could cause neuropathic pain such as diabetic neuropathy
- Significant cognitive deficits
- Chronic pain syndrome (e.g. fibromyalgia, phantom pain, rheumatoid arthritis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of Southwest Jutland
Esbjerg, Region Syddanmark, 6700, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bibi (Valgerdur) Gram, PhD
Esbjerg Hospital - University Hospital of Southern Denmark
- STUDY DIRECTOR
Carsten Kock-Jensen, MD
Esbjerg Hospital - University Hospital of Southern Denmark
- PRINCIPAL INVESTIGATOR
Niels-Peter B Nielsen, PhD
Esbjerg Hospital - University Hospital of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 30, 2020
First Posted
December 14, 2020
Study Start
February 25, 2021
Primary Completion
September 1, 2022
Study Completion
January 1, 2023
Last Updated
April 24, 2023
Record last verified: 2023-04